OBESITY NEWS SOURCE

• share
• favorite_border

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial fibrillation and obesity.

• share
• favorite_border

The summer holiday break is often considered a time of fun and relaxation for school children, but hand in hand with a respite from routine comes an increase in sedentary behaviour and screen time, and in turn, poorer health and academic outcomes.

• share
• favorite_border

Studies from multiple UChicago experts show that while GLP-1RA drugs are extremely effective for weight loss and Type 2 diabetes treatment, there's no one-size-fits-all solution and physicians and patients have to consider issues like cost and side effects.

• share
• favorite_border

The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.

• share
• favorite_border

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

High insulin levels contribute to worse outcomes for Black women compared to white women who have an aggressive form of breast cancer called triple-negative breast cancer, according to a study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. A number of factors are associated with excessive weight gain, the researchers found.

• share
• favorite_border

A new study led by researchers at the American Cancer Society (ACS) shows that older adult cancer survivors with excess body weight at the time of their first cancer diagnosis are at higher risk of developing a second cancer, especially an obesity-related cancer like breast or colorectal cancer.

• share
• favorite_border

A new, large study led by researchers at the American Cancer Society (ACS) shows adults sticking to an exercise program of 15 or more metabolic equivalent hours (MET) of physical activity per week (300 or more minutes of moderate activity or 150 or more minutes of vigorous activity) decreased their risk for cancer, including obesity-related cancers, compared with no intervention.

• share
• favorite_border

Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Testosterone appears protective against developing type 2 diabetes in men who are overweight or obese and under age 65, but not in men over that age, according to a study presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Semaglutide improved taste sensitivity, changed gene expression in the tongue that’s responsible for taste perception, and changed the brain’s response to sweet tastes, according to research presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds. The research findings will be presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass and published in Nature’s npj Gut and Liver.

• share
• favorite_border

Health insurance companies often deny coverage for new medications that treat children and teens with obesity and type 2 diabetes, meaning many patients who need treatment are unable to afford it, according to a study presented at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

• share
• favorite_border

Michigan Medicine to host live q&a discussion with obesity treatment experts

• share
• favorite_border

Endocrinologists from Cedars-Sinai will present research findings and discuss advances in clinical care throughout ENDO 2024, the Endocrine Society’s annual meeting in Boston, June 1-4.